Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Glomerular diseases are significant causes of chronic kidney disease (CKD) and are categorized as either primary or secondary. FSGS, IgA nephropathy, and membranous nephropathy are the most common primary forms, while lupus nephritis predominates among secondary causes. The REGLOCOL registry seeks to define their epidemiology and clinical profile in Colombia.
REGLOCOL is a multicenter observational study with both prospective and retrospective components, enrolling adults (≥18 years) with biopsy-confirmed glomerulopathies diagnosed between 2010 and 2025. Approved by the ethics committees of the participating institutions, the registry collects clinical, histopathological, and therapeutic data through an electronic platform equipped with automated validation systems. The registry includes variables across five domains: sociodemographic data, laboratory findings, histopathology, treatment, and comorbidities. As of October 9, 2025, 864 patients had been enrolled for preliminary descriptive analysis.
The prospective registry is expanding, increasing statistical power and enabling detailed analyses. Among 864 biopsy-confirmed cases, 70.7% were primary glomerulopathies. Lupus nephritis (22.8%) and focal segmental glomerulosclerosis (22.1%) were most frequent, followed by membranoproliferative glomerulonephritis (14.1%) and IgA nephropathy (12.0%).
Lupus nephritis predominated in young adults, while focal segmental glomerulosclerosis and membranous nephropathy were more common in older individuals. Most patients were women (56.8%), of mixed ethnicity (55.6%), and from middle socioeconomic strata (49.3%).
High rates of hypertension (35.3%) and nephrotic syndrome (39.8%) underscore the need for early detection and integrated management. Preliminary findings offer valuable insights into the epidemiology of glomerular diseases in Colombia.
REGLOCOL is the first national multicenter initiative to systematically characterize glomerular diseases in Colombia. Preliminary data show a distribution comparable to other Latin American countries, with regional variations reflecting the nation’s epidemiological diversity. Primary glomerulopathies represented 70.7% of cases and secondary 29.3%, with lupus nephritis and focal segmental glomerulosclerosis being the most common. The predominance of young women and the high burden of autoimmune diseases highlight the need for early diagnosis and continuous monitoring. REGLOCOL stands as a crucial platform for research and epidemiological surveillance, with the potential to guide public health policies and strategies to reduce the burden of kidney disease in Colombia.
